ArticleMolecular therapy. Oncology2026

Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager.

Moon Jung Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.